
The company has been given manufacturing and marketing authorisation for the therapy

The platform will passively collect data to understand treatment responses in everyday life

The company also received a grant from the Michael J. Fox Foundation and Parkinson’s UK

The US-based company develops light-based therapies for neurodegenerative conditions

The company hopes the revised protocol will accelerate the development timeline of buntanetap

The alliance is aimed at developing treatments for Parkinson's and another neurodegeneration indication

The neurodegenerative condition currently affects nearly ten million people worldwide

The progressive neurodegenerative disease affects seven million people worldwide

According to WHO, the neurodegenerative disease affected more than 8.5 million people worldwide in 2019

The neurodegenerative condition affects more than 944,000 people in the UK

The progressive neurodegenerative disease affects around ten million people worldwide

The roll out follows NICE’s recommendation of the treatment in October 2023